NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Collaborations



University of Kentucky, biomarker research firm partner to fight ovarian cancer



September 22nd, 2005

Ciphergen Biosystems, Inc., (CIPH) announced the signing of a research and collaboration agreement with the University of Kentucky.

The collaboration gives Ciphergen exclusive rights to license discoveries made during the agreement and is part of the University's ongoing research in ovarian cancer.

"This agreement allows us to expand our current research in oncology by working with Doctor van Nagell and his colleagues," said Gail Page, president and chief operating officer of Ciphergen. "The University of Kentucky is a major referral center for the treatment of gynecologic malignancies. We are very pleased to be collaborating in our mutual goal to...


Source: Women's Health Weekly (2005-09-22)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login